Rachel Margolis-Goodman: Every Contribution Matters. Together, We Research Cures
Rachel Margolis-Goodman, Director of Advancement for the Versiti Blood Research Institute, shared on LinkedIn:
”It is hard to believe after a wonderful week with family and some online shopping, Giving Tuesday is here!
This past year, I decided to completely change my career and entered the fundraising world, and I am so grateful I did.
So on this giving Tuesday, perhaps you could consider giving back to the Versiti Blood Research Institute or Versiti on King!
Both the VBRI and Versiti on King is transforming blood health together!
From breakthrough research in our labs to trusted partnerships in our communities, Versiti is driving change at every level.
At Versiti Blood Research Institute, scientists are researching cures every day with the hope to eradicate blood disease.
At the VBRI we are driving breakthroughs in blood health, from stem cell biology to immunology.
This cutting edge research saves lives and will help shape the future of medicine.
Through Versiti on King (VOK), we’re connecting neighbors to resources, hosting blood typing events, community education events, and partnering with communities to improve health equity.
Through our programs this year, 170 people discovered they carry Ro-positive blood, the safest type for patients with sickle cell disease.
If you are unable to donate financially, please consider scheduling a blood donation today to help save up to 3 lives!
Every contribution matters. Together, we research cures.
Make your Giving Tuesday gift:
Stay updated on the emerging with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day